Clinical Trial Update: Taurolidine in Treating Patients With Recurrent or Progressive Glioma [Phase 1]

View source ↗

Summary

This Phase 1 trial assesses taurolidine in patients with recurrent or progressive glioma and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Taurolidine (Taurolidine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED